公开(公告)号：US20240197688A1

公开(公告)日：2024-06-20

申请号：US18287809

申请日：2022-04-19

Applicant: KOWA COMPANY, LTD.

Inventor： Noriyuki INOUE ,  Kenji SAITO ,  Toshiaki TAKIZAWA

IPC: A61K31/423 ,  A61K31/20 ,  A61P3/06

CPC classification number: A61K31/423 ,  A61K31/20 ,  A61P3/06

Abstract: The present invention addresses the problem of providing a pharmaceutical composition/drug combination which makes it possible to prevent and/or treat dyslipidemia such as hypercholesterolemia and hypertriglyceridemia, or cardiovascular diseases such as arteriosclerosis and cardiovascular events. The present invention provides a combination of a peroxisome proliferator-activated receptor (PPAR) α agonist and an ATP citrate lyase (ACL) inhibitor for preventing and/or treating dyslipidemia such as hypercholesterolemia and hypertriglyceridemia, or cardiovascular diseases such as arteriosclerosis and cardiovascular events.